Ardelyx Inc
NASDAQ:ARDX

Watchlist Manager
Ardelyx Inc Logo
Ardelyx Inc
NASDAQ:ARDX
Watchlist
Price: 5.78 USD 0.7% Market Closed
Market Cap: 1.4B USD

Relative Value

The Relative Value of one ARDX stock under the Base Case scenario is 16.61 USD. Compared to the current market price of 5.78 USD, Ardelyx Inc is Undervalued by 65%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARDX Relative Value
Base Case
16.61 USD
Undervaluation 65%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
88
vs Industry
68
Median 3Y
7.1
Median 5Y
11.5
Industry
7.9
Forward
3.4
vs History
vs Industry
Median 3Y
-22.5
Median 5Y
-14.9
Industry
23.7
Forward
-24.1
vs History
vs Industry
Median 3Y
-19.2
Median 5Y
-11.4
Industry
22
vs History
3
vs Industry
7
Median 3Y
-11.4
Median 5Y
-6.8
Industry
24.3
vs History
17
vs Industry
14
Median 3Y
8.2
Median 5Y
6
Industry
3.3
vs History
71
vs Industry
60
Median 3Y
6.5
Median 5Y
6.5
Industry
8.2
Forward
3.3
vs History
73
vs Industry
61
Median 3Y
7.6
Median 5Y
7.6
Industry
10.2
vs History
vs Industry
Median 3Y
-24.5
Median 5Y
-13.9
Industry
6.1
Forward
-45.8
vs History
vs Industry
Median 3Y
-23.8
Median 5Y
-13.5
Industry
6.5
Forward
-37.5
vs History
vs Industry
Median 3Y
-17.9
Median 5Y
-9.9
Industry
7.9
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-9.9
Industry
6.3
vs History
61
vs Industry
25
Median 3Y
8
Median 5Y
7.2
Industry
5.7

Multiples Across Competitors

ARDX Competitors Multiples
Ardelyx Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Ardelyx Inc
NASDAQ:ARDX
1.4B USD 3.5 -24.8 -38.6 -35.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
408B USD 6.8 173.8 16.8 23.8
US
Amgen Inc
NASDAQ:AMGN
177.3B USD 4.9 25.3 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD 5.3 19.1 12.9 12.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.8B USD 10 31.8 23.3 24.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.2B USD 5.8 18 17.1 19.4
AU
CSL Ltd
ASX:CSL
83.4B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.6B USD 16.4 1 206.5 162.7 197.3
NL
argenx SE
XBRU:ARGX
43.5B EUR 14.2 33.4 57.6 59.2
P/E Multiple
Earnings Growth PEG
US
Ardelyx Inc
NASDAQ:ARDX
Average P/E: 190.8
Negative Multiple: -24.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
173.8
89%
2
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19.1
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 206.5
N/A N/A
NL
argenx SE
XBRU:ARGX
33.4
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Ardelyx Inc
NASDAQ:ARDX
Average EV/EBITDA: 40.2
Negative Multiple: -38.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.8
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.3
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
11%
1.6
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.7
N/A N/A
NL
argenx SE
XBRU:ARGX
57.6
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Ardelyx Inc
NASDAQ:ARDX
Average EV/EBIT: 46.4
Negative Multiple: -35.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.9
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197.3
N/A N/A
NL
argenx SE
XBRU:ARGX
59.2
N/A N/A